-
The importation of measles into the U.S. was discussed in these pages earlier this year.
-
The Advisory Committee on Immunization Practices (ACIP) set forth new guidelines in October 2011 for the use of a quadrivalent meningococcal conjugate vaccine (MenACWY-D) in children, ages 9 to 23 months, that are at increased risk for meningococcal disease.
-
Investigators from The Netherlands conducted a prospective study to assess whether short-term travelers on immunosuppressive agents (ISA) or those with inflammatory bowel disease (IBD) had increased risk of infectious diseases compared to matched controls.
-
In this issue: New treatment for TB; safety of dabigatran; quality of antidepressants; systolic hypertension treatment; and FDA actions.
-
In this report, the new CDC recommendations for the concomitant use of isoniazid (INH) and rifapentine (RPT) administered weekly for 12 weeks as directly observed therapy (DOT) are detailed.
-
Acute mountain sickness (AMS) is a syndrome that can affect travelers who are not acclimatized and gain altitude too quickly, usually occurring above 2,500 m. (8,200 ft.) elevation.
-
Beginning in July 2012, The Joint Commission will require hospitals to improve influenza rates annually and to work toward a national goal of 90% flu vaccination of health care workers.
-
In a stunning setback to a federal move to mandate seasonal flu shots for health care workers, the Occupational Safety and Health Administration (OSHA) said there is insufficient evidence to warrant such policies and openly questioned the longstanding perception that they make patients safer, Hospital Infection Control & Prevention learned.
-
A novel solution to the historic problem of hand hygiene (HH) compliance suggests "Big Brother" and all its ominous connotations may be not such an unwelcome presence after all.
-
When I was a medicine resident 40 years ago just as the first ICUs were being introduced, treatment for life-threatening bacterial infections consisted of antibiotics, control or removal of the primary source, intravenous fluids, and vasopressors.